Tumors are chronic conditions that are rarely detected, diagnosed, or treated correctly by a single doctor. The initial assessment and treatment indications are critical for the prognosis of cancer patients.
In cancer care, assessing and examining a patient’s case from different perspectives is an important part of treatment planning. Therefore, one of the most powerful tools in cancer care and treatment today is the Cancer Commission, also known as the Tumor Board – a group of cancer specialists who evaluate and analyze individual patients’ cases to determine the best treatment options.
We are talking about a multidisciplinary commission that meets to discuss and evaluate cancer cases. The goal is to find the best solution for each patient at each stage of the treatment and monitoring program:
- Diagnostic evaluation;
- Pharmaceutical treatment
- Oncological treatment
- Surgical treatment
- Customized post-operative management
The meetings of the multidisciplinary commissions offer an opportunity for doctors from different specialties to discuss issues related to diagnosis and to jointly decide the best treatment strategy. The main goal is to improve patient care and optimize treatment outcomes by building consensus among all participating experts. Tumor Board includes oncologists, surgeons, radiotherapists and radiologists (imagers). Depending on the case, doctors with other specialties may be requested, such as: pathologists, gynecologists, thoracic surgeons, urologists, neurosurgeons, etc.